BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6752078)

  • 1. Nomifensine and imipramine in endogenous depression. A double-blind Scandinavian multicentre study.
    Dencker SJ; Lundin L; Jensen K; Klitgaard NA; Wraae O; Eggert Hansen C; Ahlfors UG; Tuomikoski S; Pihkanen T; Jorgensen HA; Ose E
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():116-44. PubMed ID: 6752078
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomifensine, imipramine and placebo in depressed outpatients.
    Rickels K; Weise CC; Sandler K; Schless A; Zal M; Norstad N
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():73-88. PubMed ID: 6752080
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind evaluation of nomifensine and imipramine in depressed outpatients.
    McCawley A
    Am J Psychiatry; 1979 Jun; 136(6):841-3. PubMed ID: 375757
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supersensitivity and nomifensine in depressed patients.
    Montgomery S; Roy D; Montgomery DB
    Adv Biochem Psychopharmacol; 1982; 32():105-11. PubMed ID: 7046359
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.
    Montgomery SA; Roy D; Wynne-Willson S; Robinson C; Montgomery DB
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):205S-211S. PubMed ID: 6337608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled randomized group comparison of nomifensine and imipramine in depressive illness.
    Forrest A; Hewett A; Nicholson P
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):215S-220S. PubMed ID: 334226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of nomifensine and imipramine.
    Woggon B; Angst J
    Psychopharmacol Bull; 1979 Jul; 15(3):29-31. PubMed ID: 386407
    [No Abstract]   [Full Text] [Related]  

  • 12. Nomifensine in the treatment of depressed geriatric patients.
    Goldstein SE; Birnbom F; Laliberte R
    J Clin Psychiatry; 1982 Jul; 43(7):287-9. PubMed ID: 7045090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mianserin: review and discussion of its double-blind studies versus nomifensine].
    Montogomery SA; Rani SJ; Roy D; Montgomery DB
    Encephale; 1981; 7(4 Suppl):485-94. PubMed ID: 7032888
    [No Abstract]   [Full Text] [Related]  

  • 14. Pooling 12 nomifensine studies for efficacy generalizability.
    Gillings D; Grizzle J; Koch G; Rickels K; Amara I; Donelan M; Hardiman S; Nash R; Sollecito W; Stager W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):78-84. PubMed ID: 6370982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of side effects and long-term experience with nomifensine from United States clinical trials.
    Yakabow AL; Hardiman S; Nash RJ
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):96-101. PubMed ID: 6370985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind clinical comparison between nomifensine and amitriptyline in the treatment of endogenous depressions.
    López-Ibor Aliño JJ; Ayuso Gutierez JL; Montejo Iglesias ML; Ramons JL
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():97-105. PubMed ID: 6752082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasts in antidepressant medications.
    Wittenborn JR
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):153S-156S. PubMed ID: 334218
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical trial comparing nomifensine and nortriptyline.
    Pöldinger W; Streichenwein SM
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():106-15. PubMed ID: 6752077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomifensine and amitriptyline in the treatment of depression. A multi-centre double-blind comparison.
    Wistedt B; Agren H; Bjaring B; Källström B; Lund M; Månsby J; Peterson LE; Roos BE
    Acta Psychiatr Scand; 1983 Sep; 68(3):212-20. PubMed ID: 6356793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
    Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
    Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.